Yahoo
KOSDAQ - Delayed Quote KRW

Medy-Tox Inc. (086900.KQ)

64,100.00 +200.00 (+0.31%)
As of 12:23:03 PM GMT+9. Market Open.
View in AlphaSpace Currency in KRW All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
251,075,703.61
247,290,289.36
228,621,968.78
221,120,683
195,096,220.13
Cost of Revenue
95,646,925.51
104,010,357.54
89,593,237.62
87,249,734
68,691,039.13
Gross Profit
155,428,778.10
143,279,931.82
139,028,731.16
133,870,949
126,405,181
Operating Expense
138,080,028.01
126,274,161
118,680,009
116,548,620
79,739,992
Operating Income
17,348,750.09
17,005,770.82
20,348,722.16
17,322,329
46,665,189
Net Non Operating Interest Income Expense
6,839,520.69
745,758.86
-801,739.11
-1,436,550
-1,702,760.02
Pretax Income
7,758,385.64
6,582,911.53
17,499,170.18
15,853,002
49,526,136.52
Tax Provision
-7,390,039.90
-9,076,078.01
1,425,398.50
6,163,181
12,930,300.92
Net Income Common Stockholders
15,319,003.11
16,594,166.58
16,954,995.44
9,755,099
37,009,995.37
Basic EPS
2.27k
2.37k
2.38k
1.31k
5.77k
Diluted EPS
2.27k
2.37k
2.38k
1.31k
5.76k
Basic Average Shares
6,821.06
6,998.81
7,132.94
7,440.96
6,418.66
Diluted Average Shares
6,821.06
6,998.81
7,132.94
7,440.96
6,420.89
Total Operating Income as Reported
17,347,351.65
17,004,372.38
20,348,722.59
17,322,329
46,664,445.39
Rent Expense Supplemental
--
670,820
442,836
527,841
479,450
Total Expenses
233,726,953.52
230,284,518.54
208,273,246.62
203,798,354
148,431,031.13
Net Income from Continuing & Discontinued Operation
15,319,003.11
16,594,166.58
16,954,995.44
9,755,099
37,009,995.37
Normalized Income
17,507,677.71
19,366,487.74
23,764,311.30
10,896,380.44
41,212,461.98
Interest Income
--
1,395,151
925,154
896,430
610,755
Interest Expense
--
649,393
1,726,893
2,332,980
2,313,515
Net Interest Income
6,839,520.69
745,758.86
-801,739.11
-1,436,550
-1,702,760.02
EBIT
7,575,283.80
7,232,304.53
19,226,063.18
18,185,982
51,839,651.52
EBITDA
7,575,283.80
27,298,905.53
39,184,832.18
33,561,701
66,940,846.52
Reconciled Cost of Revenue
95,646,925.51
104,010,357.54
89,593,237.62
87,249,734
68,691,039.13
Reconciled Depreciation
--
20,066,601
19,958,769
15,375,719
15,101,195
Net Income from Continuing Operation Net Minority Interest
15,319,003.11
16,594,166.58
16,954,995.44
9,755,099
37,009,995.37
Total Unusual Items Excluding Goodwill
-3,647,791
-3,647,791
-7,413,156
-1,867,190
-5,687,312
Total Unusual Items
-3,647,791
-3,647,791
-7,413,156
-1,867,190
-5,687,312
Normalized EBITDA
11,223,074.80
30,946,696.53
46,597,988.18
35,428,891
72,628,158.52
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,459,116.40
-875,469.84
-603,840.14
-725,908.56
-1,484,845.39
12/31/2022 - 1/16/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: